Acquisition by Michael Crowley of 433 shares of Bio Rad subject to Rule 16b-3
BIO Stock | USD 338.48 0.75 0.22% |
About 64% of Bio Rad's investor base is looking to short. The analysis of overall sentiment of trading Bio Rad Laboratories stock suggests that many investors are alarmed at this time. Bio Rad's investing sentiment overview a quick insight into current market opportunities from investing in Bio Rad Laboratories. Many technical investors use Bio Rad Laboratories stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Bio |
Filed transaction by Bio Rad Laboratories Officer Evp, Gbl Commercial Operations. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Bio Rad's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Bio Rad's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Bio Rad Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Bio Rad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bio Rad Laboratories Historical Investor Sentiment
Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Rad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Rad and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Rad news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Rad.
Bio Rad Fundamental Analysis
We analyze Bio Rad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Bio Rad is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Bio Rad Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Rad stock to make a market-neutral strategy. Peer analysis of Bio Rad could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics with similar companies.
Peers
Bio Rad Related Equities
NVCR | Novocure | 10.12 | ||||
TNDM | Tandem Diabetes | 3.93 | ||||
ANIK | Anika Therapeutics | 3.02 | ||||
INSP | Inspire Medical | 2.57 | ||||
BRKR | Bruker | 1.53 | ||||
ITGR | Integer Holdings | 1.46 | ||||
GKOS | Glaukos Corp | 1.39 | ||||
ZBH | Zimmer Biomet | 1.25 | ||||
GMED | Globus Medical | 0.90 | ||||
STE | STERIS Plc | 0.65 | ||||
NARI | Inari Medical | 0.39 | ||||
DXCM | DexCom | 0.21 | ||||
PODD | Insulet | 0.19 | ||||
CNMD | CONMED | 0.99 | ||||
PEN | Penumbra | 1.93 |
Check out Bio Rad Hype Analysis, Bio Rad Correlation and Bio Rad Performance. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.412 | Earnings Share (28.09) | Revenue Per Share 90.815 | Quarterly Revenue Growth 0.028 | Return On Assets 0.0186 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.